Our activities incorporate all areas of the pharmaceutical value chain
Click here and learn moreInnovation is one of the pillars of our strategy. We devote approximately EUR 50 million to research and development.
Click here and learn moreEgis ’products are available in 71 countries. Our portfolio consists of 647 products. Our main focus lies on treating diseases of the cardiovascular and central nervous systems.
Learn more about our products